Greehey Children's Cancer Research Institute

Organization profile

Organization profile

Since 2004, UT Health San Antonio, Greehey Children’s Cancer Research Institute’s (GCCRI) mission has been to advance scientific knowledge relevant to childhood cancer, contribute to the understanding of causes of childhood cancer, and accelerate the translation of knowledge into novel therapies. Through discovery, development  and dissemination of new scientific knowledge, GCCRI strives to have a national and global impact on the problem of childhood cancer. Our mission consists of three key areas — research, clinical and education.

Greehey Children’s Cancer Research Institute does not participate directly in patient care, but interacts with members of the Division of Pediatric Hematology-Oncology to provide support for clinical research. Research services at the Institute include: genome sequencing, small animal imaging and computational biology and bioinformatics.

More...

Fingerprint Dive into the research topics where Greehey Children's Cancer Research Institute is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

    • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Profiles

    No photo of Christine Aguilar

    Christine Aguilar

    Person: Academic

    19882017
    No photo of Gregory Aune

    Gregory Aune

    Person: Academic

    20022019
    No photo of Alexander J Bishop

    Alexander J Bishop

    Person: Academic

    19972018

    Projects

    miRNAs:Safe and effective therapeutic adjuvants for treating drug resistant TNBC

    Rao, M. K. & Vadlamudi, R. K.

    National Institutes of Health

    2/1/15 → 1/31/20

    Project: Research project

    • Importance of Androgen regulated miRNAs in male fertility

    Rao, M. K.

    National Institutes of Health

    7/15/14 → 4/30/16

    Project: Research project

    • Determination of Musashi1/CD44v6 signaling in mesenchymal glioma stem cells

    Penalva, L. O., Nakano, I. & Penalva, L. O.

    National Institutes of Health

    1/1/14 → 12/31/15

    Project: Research project

    • Research Output

    A new vaccine targeting RANKL, prepared by incorporation of an unnatural Amino acid into RANKL, prevents OVX-induced bone loss in mice

    Li, F., Li, H., Zhai, Q., Li, F., Wu, T., Sha, X., Zhang, B., Yang, W., Lu, Z. & Tao, H., May 15 2018, In : Biochemical and Biophysical Research Communications. 499, 3, p. 648-654 7 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Distinct roles of XPF-ERCC1 and Rad1-Rad10-Saw1 in replication-coupled and uncoupled inter-strand crosslink repair

    Seol, J. H., Holland, C., Li, X., Kim, C., Li, F., Medina-Rivera, M., Eichmiller, R., Gallardo, I. F., Finkelstein, I. J., Hasty, P., Shim, E. Y., Surtees, J. A. & Lee, S. E., Dec 1 2018, In : Nature communications. 9, 1, 4327.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models

    Bandyopadhyay, A., Favours, E., Phelps, D. A., Pozo, V. D., Ghilu, S., Kurmashev, D., Michalek, J., Trevino, A., Guttridge, D., London, C., Hirotani, K., Zhang, L., Kurmasheva, R. T. & Houghton, P. J., Feb 1 2018, In : Pediatric Blood and Cancer. 65, 2, e26870.

    Research output: Contribution to journal › Article

    • 3 Scopus citations

    Press / Media

    bioAffinity Technologies Announces Members of its Scientific and Medical Advisory Board

    Vivienne I Rebel

    10/2/19

    10 items of Media coverage

    Press/Media: Press / Media